Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement ...

B iodesix has expanded its collaboration with Bio-Rad Laboratories for the development and clinical validation of in vitro diagnostic (IVD) assays, designed to facilitate the identification of a ...

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Voss and his team have used CRISPR gene-editing to reprogram human B cells to produce antibodies that can recognize and block many different strains of HIV. And although existing humanized mouse ...